The short answer
Nopal can change meal-related glucose responses, but hypoglycemia from combining Opuntia ficus-indica with regular human insulin has not been established. Studies of steamed plant material and capsules have different results.
What this answer covers
Opuntia ficus-indica exact species; steamed nopal, dried capsules, fruit and extracts are different exposures.
- Supplement or preparation
- Opuntia ficus-indica
- Medication ingredient
- insulin, regular, human
Meal effects depend on preparation
A small study found lower post-meal glucose with steamed nopal in a high-carbohydrate breakfast. Responses differed with the meal composition. This is a food experiment, not a measured regular-insulin interaction.
Capsule findings were less clear
A separate study found no acute glucose or glucose-tolerance effect from dried nopal capsules. In its diabetic crossover arm, usual glucose-lowering medicine was withdrawn, so it cannot establish the safety or harm of combination use.
Glucose lowering does not prove hypoglycemia
Neither inspected abstract provides an exact regular-insulin co-use analysis or a rate of clinically low glucose. The species name also cannot make concentrated extracts equivalent to the studied steamed plant or capsules.
Keep the diabetes team informed
Discuss the exact product and amount with the diabetes team before starting or changing it. Follow your established glucose-monitoring and low-glucose treatment plan; do not adjust insulin yourself. Discuss major dietary changes as well as supplements; do not replace insulin with nopal.
Evidence and practical considerations
Side effects & toxicity
Indirect preparation-specific clinical evidence does not establish added hypoglycemia with regular human insulin.
- Exact scope
- Opuntia ficus-indica exact species; steamed nopal, dried capsules, fruit and extracts are different exposures. with Regular human insulin RxCUI253182 IN; U100/U500 and routes distinct.
- Medication form and route
- injected regular human insulin; oral supplement
What remains uncertain
- No exact herb-event rate or arbitrary insulin change.
Factors that may matter: Concentration; Route; Meals; Product; Other diabetes treatment.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed regular human insulin
Hypoglycemia can be severe. Niacin may decrease glucose lowering. Treatment changes can require increased monitoring and clinician review. Subcutaneous dose given30minutes before meals.
How this applies: Exact RxCUI253182 IN regular human insulin; U100/U500 distinguished from NPH and rapid analogs.
Product concentration, devices, route and action profile matter. No supplement-specific adverse-event incidence.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed regular human insulin
Hypoglycemia can be severe. Niacin may decrease glucose lowering. Treatment changes can require increased monitoring and clinician review. Subcutaneous dose given30minutes before meals. Concentration gives a different time course with both prandial and basal activity.
How this applies: Exact RxCUI253182 IN regular human insulin; U100/U500 distinguished from NPH and rapid analogs.
Product concentration, devices, route and action profile matter. No supplement-specific adverse-event incidence.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 14type 2 diabetes participants; separate index study in7healthy people.
Steamed nopal lowered post-meal glucose response with a high-carbohydrate breakfast; meal composition affected responses.
How this applies: Indirect for exact regular human insulin; source drug, preparation and endpoint retained.
14diabetic participants in meal experiment; no exact regular-insulin co-use or clinical hypoglycemia analysis in abstract. Food preparation does not represent every extract.
Source 4: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 10diabetic acute participants,10healthy OGTT participants,14diabetic crossover participants and5healthy participants.
Dried nopal capsules showed no acute glucose-lowering effect or OGTT effect; chronic comparison largely reflected glucose worsening during placebo.
How this applies: Indirect for exact regular human insulin; source drug, preparation and endpoint retained.
Small studies; oral hypoglycemic treatment withdrawn in diabetic crossover arm, so not combination evidence.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact regular-insulin article with route, concentration and clinical endpoint boundaries. | |
| Research summary published |
Article revision: 826fd1c2124c5da2
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.